WallStreetZenWallStreetZen

NASDAQ: DMAC
Diamedica Therapeutics Inc Stock Ownership - Who owns Diamedica Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Diamedica Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard D. PilnikDirector2025-04-0724,000$2.11
$50.64kBuy
Randall Michael GiuffreDirector2025-02-1312,000$2.11
$25.32kBuy
Randall Michael GiuffreDirector2025-02-135,000$3.65
$18.25kBuy
Richard D. PilnikDirector2025-01-0210,393$5.34
$55.50kBuy
Randall Michael GiuffreDirector2025-01-0210,861$5.34
$58.00kBuy
Charles Pauling SembaDirector2025-01-025,290$5.34
$28.25kBuy
Richard KuntzDirector2025-01-029,925$5.34
$53.00kBuy
James T. ParsonsDirector2025-01-0215,917$5.34
$85.00kBuy

1 of 1

DMAC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DMAC insiders and whales buy or sell their stock.

DMAC Shareholders

What type of owners hold Diamedica Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Koch Thomas Von25.72%11,030,155$40.04MInsider
Jan Stahlberg21.55%9,243,216$33.55MInsider
Richard Jacinto Ii10.63%4,558,823$16.55MInsider
Cooperman Leon G3.79%1,625,000$5.90MInstitution
Vanguard Group Inc3.15%1,351,467$4.91MInstitution
Zhenyu Xiao2.35%1,007,100$3.66MInsider
First Manhattan Co LLC1.41%606,435$2.20MInstitution
Paragon Associates Paragon Associates II Joint Venture1.40%600,000$2.18MInstitution
Susquehanna International Group LLP1.30%556,593$2.02MInstitution
David J. Wambeke1.23%527,114$1.91MInsider

1 of 3

DMAC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMAC17.52%64.28%Net Buying
SPRO27.02%64.48%Net Selling
CCCC78.01%21.99%Net SellingNet Buying
GALT11.50%88.50%Net BuyingNet Buying
IMRX12.50%38.93%Net BuyingNet Buying
View Top Biotech Stocks

Diamedica Therapeutics Stock Ownership FAQ

Who owns Diamedica Therapeutics?

Diamedica Therapeutics (NASDAQ: DMAC) is owned by 17.52% institutional shareholders, 64.28% Diamedica Therapeutics insiders, and 18.20% retail investors. Koch Thomas Von is the largest individual Diamedica Therapeutics shareholder, owning 11.03M shares representing 25.72% of the company. Koch Thomas Von's Diamedica Therapeutics shares are currently valued at $40.04M.

If you're new to stock investing, here's how to buy Diamedica Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.